Johnson & Johnson
featured
The "Fast Money" traders share their final trades of the day.
» Read More
 2.160x105.jpg?v=1369079618 "Cramer: Invest Like the Ridiculously Rich")
More
-
Allergan rose$. 38 or. 4 percent, to $103.53. Baxter International Inc. fell$. 30 or. 4 percent, to $70.69. Boston Scientific Corp. rose$. 12 or 1.4 percent, to $8.42.
-
Baxter International Inc. fell$. 30 or. 4 percent, to $70.69. Bristol-Myers Squibb Co. rose$. 22 or. 6 percent, to $40.15. Hospira rose$. 04 or. 1 percent, to $34.59.
-
Baxter International Inc. rose$. 03 or percent, to $71.02. Bristol-Myers Squibb Co. rose$. 25 or. 6 percent, to $40.18. Hospira fell$. 02 or. 1 percent, to $34.53.
-
Allergan rose $1.15 or 1.1 percent, to $104.30. Baxter International Inc. rose$. 03 or percent, to $71.02. Boston Scientific Corp. rose$. 23 or 2.8 percent, to $8.53.
-
Baxter International Inc. fell$. 28 or. 4 percent, to $70.99. Bristol-Myers Squibb Co. rose$. 25 or. 6 percent, to $39.93. Hospira rose$. 95 or 2.8 percent, to $34.55.
-
Allergan fell$. 16 or. 2 percent, to $103.15. Baxter International Inc. fell$. 28 or. 4 percent, to $70.99. Boston Scientific Corp. rose$. 45 or 5.7 percent, to $8.30.
-
SEATTLE-- Dendreon Corp. said Thursday that sales of its prostate cancer therapy Provenge fell in the first quarter because of increased competition from two newer drugs. Net revenue from Provenge fell 18 percent to $67.6 million, Dendreon said. Dendreon said it lost $72 million, or 48 cents per share, in the three months ended March 31.
-
Allergan rose$. 46 or. 4 percent, to $103.77. Baxter International Inc. rose$. 02 or percent, to $71.29. Boston Scientific Corp. rose$. 29 or 3.7 percent, to $8.14.
-
Baxter International Inc. rose$. 02 or percent, to $71.29. Bristol-Myers Squibb Co. rose$. 13 or. 3 percent, to $39.81. Hospira rose$. 75 or 2.2 percent, to $34.35.
-
Allergan rose$. 11 or. 1 percent, to $103.42. Baxter International Inc. fell$. 07 or. 1 percent, to $71.20. Boston Scientific Corp. rose$. 21 or 2.6 percent, to $8.06.
-
Baxter International Inc. fell$. 07 or. 1 percent, to $71.20. Bristol-Myers Squibb Co. fell$. 22 or. 6 percent, to $39.46. Hospira rose$. 30 or. 9 percent, to $33.90.
-
After approvals last year from the FDA for 39 novel medicines- a record only beaten in 1996- the healthy pace has continued into 2013.. And drugmakers are getting further help from a new FDA program to accelerate life-saving therapies designated as a "breakthrough," opening to door to earlier approval based on quicker studies, where clinical data is compelling.
-
By Sharon Begley and Ransdell Pierson. May 7- New Jersey Governor Chris Christie's choice of gastric banding has prompted questions about why he opted for a weight-loss procedure less favored by bariatric surgeons and patients.
-
NEW YORK, May 7- In a blow for Alzheimer's patients, Baxter International Inc said it will scrap late-stage trials of its antibody treatment for the disease after the drug failed to improve cognitive decline and functional ability in patients.
-
NEW YORK, May 7- In a blow for Alzheimer's patients, Baxter International Inc said it will scrap late-stage trials of its antibody treatment for the disease after the drug failed to improve cognitive decline and functional ability in patients.
-
*The scripps research institute announces new research and license agreement. *The scripps research institute- agreement with janssen to collaborate on. focused research projects in infectious disease area.
-
*Established drug products in focus at Pfizer, GSK, Sanofi. Bankers speaking at the Reuters Health Summit said the success of transactions such as Pfizer Inc's divestitures of noncore assets and Abbott Laboratories splitting off its innovative drugs into AbbVie Inc had fuelled a wider rethink across the industry.
-
NEW YORK, May 6- The S&P 500 closed at another record high, pushing further above 1,600 as financial shares led the way after Bank of America's settlement with MBIA. Bank of America said it would settle claims with MBIA for $1.6 billion, lifting shares of both companies as well as the S&P financial sector Index, which gained 1 percent.
-
NEW YORK, May 6- U.S. stocks inched higher on Monday, lifted by financials and Apple shares, as Wall Street extended a rally that pushed the Dow and S&P 500 to record highs last week. Shares of MBIA jumped nearly 50 percent to $14.46 following a news report regarding a settlement of ongoing dispute with Bank of America. Bank of America shares were up 4 percent at $12.74.
-
NEW YORK, May 6- U.S. stocks edged up on Monday, boosted by the tech sector, as Wall Street extended a rally that pushed the Dow and S&P 500 to record highs last week on improving earnings and reassuring signs about the economy. Apple shares were among the top gainers after Barclays raised its price target on the stock.